BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for Aravive, Inc. (ARAV)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Aravive, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2024-02-14
10:24 am
Purchase		2023-12-3113GAravive, Inc.
ARAV		BIOTECHNOLOGY VALUE FUND L P8,164,510
9.990%		2,055,452increase
(+33.65%)		Filing
2022-11-07
4:50 pm
Purchase		2022-10-2713GAravive, Inc.
ARAV		BIOTECHNOLOGY VALUE FUND L P6,109,058
9.990%		6,109,058increase
(New Position)		Filing